Nevertheless, later, Papi et al. proposed that the combination of 6-OH-11-O-hydroxyphenantrene (IIF) with PPARγ ligands, including ciglitazone and pioglitazone, inhibited the proliferation and invasion of colon cancer cell lines [116]. The gene discussed is PPARG; the disease is colonic neoplasm.